Share Facebook Twitter LinkedIn Pinterest Email Jeff Bezos shakes up Blue Origin staff incentives ahead of SpaceX IPO: FT
Neurocrine reaffirms $2.7B-$2.8B INGREZZA outlook while acquisition of Soleno remains on track for Q2 close (NASDAQ:NBIX)May 6, 2026
Jacobs outlines FY ’29 targets of 17%+ adjusted EBITDA margin and $1.2B-$1.3B annual free cash generation (NYSE:J)May 6, 2026
